A French Multi-centric Atrial Fibrillation Catheter Ablation Survey (FrenchAF)

August 6, 2013 updated by: Serge Boveda, Clinique Pasteur

Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients.

We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.

Study Overview

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toulouse, France
        • Clinique Pasteur

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients undergoing catheter ablation in one of the registry centers

Description

Inclusion Criteria:

  • all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter

Exclusion Criteria:

  • patients undergoing catheter ablation of other types of arrhythmia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pasteur
electric pulmonary vein disconnection
Grenoble
electric pulmonary vein disconnection
Nantes
electric pulmonary vein disconnection
Parly
electric pulmonary vein disconnection
Rennes
electric pulmonary vein disconnection
Rouen
electric pulmonary vein disconnection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Atrial fibrillation relapse
Time Frame: starting 3 months after the procedure till an average of 18months follow-up
Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure
starting 3 months after the procedure till an average of 18months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Early atrial fibrillation relapse
Time Frame: first 3 months
Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure
first 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2010

Primary Completion (Actual)

July 1, 2013

Study Completion (Anticipated)

December 1, 2013

Study Registration Dates

First Submitted

August 6, 2013

First Submitted That Met QC Criteria

August 6, 2013

First Posted (Estimate)

August 8, 2013

Study Record Updates

Last Update Posted (Estimate)

August 8, 2013

Last Update Submitted That Met QC Criteria

August 6, 2013

Last Verified

August 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Observation of Outcome After Catheter Ablation of Atrial Fibrillation

Clinical Trials on catheter ablation of atrial fibrillation

Subscribe